08:36 AM EDT, 04/23/2024 (MT Newswires) -- Kiniksa Pharmaceuticals ( KNSA ) reported a Q1 net loss Tuesday of $0.25 per diluted share, widening from a per-share loss of $0.18 a year earlier.

Three analysts polled by Capital IQ expected a per-share loss of $0.16.

Revenue for the quarter ended March 31 was $79.9 million, up from $48.3 million a year earlier.

Four analysts surveyed by Capital IQ expected $78.5 million.